Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
March 08 2024 - 12:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of March 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
Board Committee Change
GSK plc today announces the following change to its Board Committee
membership with effect from 11 March 2024:
Dr Hal Dietz has been appointed a member of the Nominations &
Corporate Governance Committee. This appointment is in addition to
his role as Chair of the Science Committee and membership of the
Chairs' Committee.
V A Whyte
Company Secretary
8 March 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
GSK plc
|
|
(Registrant)
|
|
|
Date: March
08, 2024
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Jul 2024 to Aug 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Aug 2023 to Aug 2024